Pharmaceutical

Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board Member

WINNIPEG, MB / ACCESSWIRE / November 18, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused…

1 year ago

Community Routes: Access to Mental Health Care

US Chamber of Commerce Foundation Citizens Award WinnerNORTHAMPTON, MA / ACCESSWIRE / November 18, 2024 / Teva Pharmaceuticals is proud…

1 year ago

Cardiol Therapeutics’ Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024

Marked and rapid reductions in both pericarditis pain and inflammation  maintained throughout the 26-week studyEpisodes of pericarditis per year substantially…

1 year ago

SEEHER, ABBOTT, AND CVS RELEASE FIRST-EVER HEALTH AND WELLNESS REPORT TO COMBAT HOW WOMEN HAVE BEEN DEPRIORITIZED AND UNDERREPRESENTED IN HEALTHCARE MARKETING

Women are the key decision makers in 80% of all healthcare choices, yet many brands fail to accurately portray them…

1 year ago

ODAIA Named Only “Major Contender” and “Star Performer” in Everest Group’s PEAK Matrix® Assessment

Independent research firm honors ODAIA as a next-generation customer engagement platform for life sciences BOSTON, Nov. 18, 2024 /PRNewswire/ -- ODAIA today…

1 year ago

Lunit Announces Collaboration with AstraZeneca to Develop AI-Powered Digital Pathology Risk Assessment Tools for NSCLC

Collaboration to harness Lunit SCOPE Genotype Predictor for rapid and convenient prediction of non-small cell lung cancer driver mutations SEOUL,…

1 year ago

NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo

OPKO Healthcare's Veterinary Care Products to be Introduced at Asia's Largest Health and Nutrition Tradeshow Company Invited to Present at…

1 year ago

EW Healthcare Partners Announces Leadership Evolution

Dr. Petri Vainio to become Executive ChairmanDr. Evis Hursever to become CEOScott Barry to become COOMarty Sutter to become Founding…

1 year ago

Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements

Two patients exceed 14 months on treatment in Phase 2 trial of advanced ovarian cancerAllarity maintains a cash balance of…

1 year ago